ASTRO: Shorter radiation OK for early breast cancers

ASTRO: shorter radiation OK for early breast cancers

(HealthDay)—Hypofractionated radiation therapy with incorporated boost over a shorter period of time treats early-stage breast cancer as well as longer, conventional radiation therapy, a new study suggests. The findings were scheduled to be presented at the annual meeting of the American Society for Radiation Oncology, held from Oct. 18 to 21 in San Antonio.

Researchers from Fox Chase Cancer Center-Temple Health in Philadelphia report that eight years after treatment, there were no significant differences in survival among hundreds of patients who received hypofractionated whole-breast radiation with incorporated boost over four weeks or conventional fractionation with sequential boost.

"This is good news for cancer patients because a shorter length of treatment is not only more convenient, but it helps to enable a woman to get her life back to normal after treatment," Stephanie Bernik, M.D., chief of surgical oncology at Lenox Hill Hospital in New York City, told HealthDay.

"At this time, the shorter is offered to a select group of women," Bernik added. "With more and more studies showing equivalence, the hope is that this therapy can be expanded to women with even more aggressive cancers."

Explore further

Not all large breast tumors warrant mastectomy, study says

More information: Abstract
More Information

Copyright © 2015 HealthDay. All rights reserved.

Citation: ASTRO: Shorter radiation OK for early breast cancers (2015, October 21) retrieved 26 September 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments